• Je něco špatně v tomto záznamu ?

N-substituted 2-isonicotinoylhydrazinecarboxamides--new antimycobacterial active molecules

Z. Rychtarčíková, M. Krátký, M. Gazvoda, M. Komlóová, S. Polanc, M. Kočevar, J. Stolaříková, J. Vinšová,

. 2014 ; 19 (4) : 3851-3868.

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008141

Grantová podpora
NT13346 MZ0 CEP - Centrální evidence projektů

This report presents a new modification of the isoniazid (INH) structure linked with different anilines via a carbonyl group obtained by two synthetic procedures and with N-substituted 5-(pyridine-4-yl)-1,3,4-oxadiazole-2-amines prepared by their cyclisation. All synthesised derivatives were characterised by IR, NMR, MS and elemental analyses and were evaluated in vitro for their antimycobacterial activity against Mycobacterium tuberculosis H37Rv, Mycobacterium avium 330/88, Mycobacterium kansasii 235/80 and one clinical isolated strain of M. kansasii 6509/96. 2-Isonicotinoyl-N-(4-octylphenyl)hydrazinecarboxamide displayed an in vitro efficacy comparable to that of INH for M. tuberculosis with minimum inhibitory concentrations (MICs) of 1-2 μM. Among the halogenated derivatives, the best anti-tuberculosis activity was found for 2-isonicotinoyl-N-(2,4,6-trichlorophenyl)hydrazinecarboxamide (MIC=4 μM). In silico modelling on the enoyl-acyl carrier protein reductase InhA confirmed that longer alkyl substituents are advantageous for the interactions and affinity to InhA. Most of the hydrazinecarboxamides, especially those derived from 4-alkylanilines, exhibited significant activity against INH-resistant nontuberculous mycobacteria.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008141
003      
CZ-PrNML
005      
20181212134739.0
007      
ta
008      
150306s2014 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/molecules19043851 $2 doi
035    __
$a (PubMed)24686575
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Rychtarčíková, Zuzana $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. rychtarz@faf.cuni.cz.
245    10
$a N-substituted 2-isonicotinoylhydrazinecarboxamides--new antimycobacterial active molecules / $c Z. Rychtarčíková, M. Krátký, M. Gazvoda, M. Komlóová, S. Polanc, M. Kočevar, J. Stolaříková, J. Vinšová,
520    9_
$a This report presents a new modification of the isoniazid (INH) structure linked with different anilines via a carbonyl group obtained by two synthetic procedures and with N-substituted 5-(pyridine-4-yl)-1,3,4-oxadiazole-2-amines prepared by their cyclisation. All synthesised derivatives were characterised by IR, NMR, MS and elemental analyses and were evaluated in vitro for their antimycobacterial activity against Mycobacterium tuberculosis H37Rv, Mycobacterium avium 330/88, Mycobacterium kansasii 235/80 and one clinical isolated strain of M. kansasii 6509/96. 2-Isonicotinoyl-N-(4-octylphenyl)hydrazinecarboxamide displayed an in vitro efficacy comparable to that of INH for M. tuberculosis with minimum inhibitory concentrations (MICs) of 1-2 μM. Among the halogenated derivatives, the best anti-tuberculosis activity was found for 2-isonicotinoyl-N-(2,4,6-trichlorophenyl)hydrazinecarboxamide (MIC=4 μM). In silico modelling on the enoyl-acyl carrier protein reductase InhA confirmed that longer alkyl substituents are advantageous for the interactions and affinity to InhA. Most of the hydrazinecarboxamides, especially those derived from 4-alkylanilines, exhibited significant activity against INH-resistant nontuberculous mycobacteria.
650    _2
$a aminy $x chemie $7 D000588
650    _2
$a aniliny $x chemie $7 D000814
650    _2
$a antituberkulotika $x chemická syntéza $x farmakologie $7 D000995
650    _2
$a azoly $x chemie $7 D001393
650    _2
$a bakteriální proteiny $x antagonisté a inhibitory $x chemie $7 D001426
650    _2
$a cyklizace $7 D003500
650    _2
$a bakteriální léková rezistence $7 D024881
650    _2
$a lidé $7 D006801
650    _2
$a isoniazid $x analogy a deriváty $x chemická syntéza $x farmakologie $7 D007538
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a simulace molekulového dockingu $7 D062105
650    _2
$a atypické mykobakteriální infekce $x mikrobiologie $7 D009165
650    _2
$a Mycobacterium avium $x účinky léků $x enzymologie $x růst a vývoj $7 D009162
650    _2
$a Mycobacterium kansasii $x účinky léků $x enzymologie $x růst a vývoj $x izolace a purifikace $7 D019909
650    _2
$a Mycobacterium tuberculosis $x účinky léků $x enzymologie $x růst a vývoj $7 D009169
650    _2
$a oxidoreduktasy $x antagonisté a inhibitory $x chemie $7 D010088
650    _2
$a pyridiny $x chemie $7 D011725
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Krátký, Martin $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. martin.kratky@faf.cuni.cz. $7 jo2017947786
700    1_
$a Gazvoda, Martin $u Faculty of Chemistry and Chemical Technology, University of Ljubljana, Aškerčeva 5, SI-1000 Ljubljana, Slovenia. martin.gazvoda@fkkt.uni-lj.si.
700    1_
$a Komlóová, Markéta $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. komlm3aa@faf.cuni.cz. $7 _AN046724
700    1_
$a Polanc, Slovenko $u Faculty of Chemistry and Chemical Technology, University of Ljubljana, Aškerčeva 5, SI-1000 Ljubljana, Slovenia. Slovenko.Polanc@fkkt.uni-lj.si.
700    1_
$a Kočevar, Marijan $u Faculty of Chemistry and Chemical Technology, University of Ljubljana, Aškerčeva 5, SI-1000 Ljubljana, Slovenia. marijan.kocevar@fkkt.uni-lj.si.
700    1_
$a Stolaříková, Jiřina $u Laboratory for Mycobacterial Diagnostics and Tuberculosis, Regional Institute of Public Health in Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic. Jirina.Stolarikova@zu.cz.
700    1_
$a Vinšová, Jarmila, $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. jarmila.vinsova@faf.cuni.cz. $d 1951- $7 nlk19990073991
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 19, č. 4 (2014), s. 3851-3868
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24686575 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20181212134904 $b ABA008
999    __
$a ok $b bmc $g 1065414 $s 890941
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 19 $c 4 $d 3851-3868 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
GRA    __
$a NT13346 $p MZ0
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Možnosti archivace